FAAR vs CANC

Comparison between FIRST TRUST ALTERNATIVE ABSOLUTE RETURN STRATEGY ETF (FAAR, ETF) and Tema Oncology ETF (CANC, ETF).

5-Year PerformanceFAAR has outperformed CANC, delivering a return of +7.5% compared to -9.4%

FAAR vs CANC - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	FAAR(ETF)	CANC(ETF)
Net Assets	$176M	$176M
Expense Ratio	0.98%	0.75%
Max Drawdown	27.93%	97.53%
Sharpe Ratio	2.03	1.52
5Y Beta	0.15	0.75
P/E Ratio	N/A	-24.37
5Y Dividends CAGR	31.47%	N/A
5Y EPS CAGR	N/A	11.01%
Debt to Equity	N/A	58.15%
P/S Ratio	N/A	8.49
P/B Ratio	N/A	5.96

Net Assets

FAAR

$176M

Winner

CANC

$176M

Expense Ratio

FAAR

0.98%

Winner

CANC

0.75%

Max Drawdown

Winner

FAAR

27.93%

CANC

97.53%

Sharpe Ratio

Winner

FAAR

2.03

CANC

1.52

5Y Beta

Winner

FAAR

0.15

CANC

0.75

P/E Ratio

FAAR

N/A

CANC

-24.37

5Y Dividends CAGR

FAAR

31.47%

CANC

N/A

5Y EPS CAGR

FAAR

N/A

CANC

11.01%

Debt to Equity

FAAR

N/A

CANC

58.15%

P/S Ratio

FAAR

N/A

CANC

8.49

P/B Ratio

FAAR

N/A

CANC

5.96

FAAR vs CANC - Holdings Comparison

FAAR and CANC have 0 common holdings. Overlap is 0.00%

FAAR's top 25 holdings weight is 16.37%. CANC's top 25 holdings weight is 76.89%.

Rank	FAAR	CANC
#1	MORGAN STANLEY INSTL LQUDTY TRS INSTL (MISXX) - 16.37%	REVOLUTION MEDICINES INC ORDINARY SHARES (RVMD) - 7.31%
#2	N/A	ELI LILLY AND CO (LLY) - 4.25%
#3	N/A	IMMUNOME INC ORDINARY SHARES (IMNM) - 4.21%
#4	N/A	COGENT BIOSCIENCES INC (COGT) - 4.08%
#5	N/A	ROCHE HOLDING AG ADR (RHHBY) - 4.07%
#6	N/A	NOVARTIS AG REGISTERED SHARES (n/a) - 4.00%
#7	N/A	CELCUITY INC (CELC) - 3.93%
#8	N/A	ASTRAZENECA PLC (AZN:XLON) - 3.50%
#9	N/A	MERCK & CO INC (MRK) - 3.43%
#10	N/A	BRISTOL-MYERS SQUIBB CO (BMY) - 3.34%
#11	N/A	NUVALENT INC CLASS A (NUVL) - 3.15%
#12	N/A	LEGEND BIOTECH CORP ADR (LEGN) - 2.94%
#13	N/A	GENMAB AS ADR (GMAB) - 2.87%
#14	N/A	ABBVIE INC (ABBV) - 2.70%
#15	N/A	BRIDGEBIO PHARMA INC (BBIO) - 2.63%
#16	N/A	CG ONCOLOGY INC (CGON) - 2.56%
#17	N/A	JOHNSON & JOHNSON (JNJ) - 2.55%
#18	N/A	ZAI LAB LTD ADR REPR 1 SHS (ZLAB) - 2.49%
#19	N/A	EXELIXIS INC (EXEL) - 2.45%
#20	N/A	IDEAYA BIOSCIENCES INC (IDYA) - 2.10%
#21	N/A	AMGEN INC (AMGN) - 2.04%
#22	N/A	BEONE MEDICINES LTD ADR (ONC) - 1.95%
#23	N/A	ZYMEWORKS INC REGISTERED SHS (ZYME) - 1.62%
#24	N/A	FIRST AMERICAN TREASURY OBLIGS X (FXFXX) - 1.47%
#25	N/A	ANAPTYSBIO INC (ANAB) - 1.25%
Total Holdings	1	57

FAAR vs CANC - Historical Returns

Returns include dividend reinvestment.

Period	FAAR	CANC
1 month	-2.79%	-0.45%
3 months	-1.84%	+3.17%
6 months	+22.36%	+8.22%
1 year	+32.87%	+43.36%
5 years(CAGR)	+7.52%	-9.38%
10 years(CAGR)	+4.91%	N/A
Max(CAGR)	+4.88%	-9.38%

FAAR

-2.79%

Winner

CANC

-0.45%

FAAR

-1.84%

Winner

CANC

+3.17%

Winner

FAAR

+22.36%

CANC

+8.22%

FAAR

+32.87%

Winner

CANC

+43.36%

5Y(CAGR)

Winner

FAAR

+7.52%

CANC

-9.38%

10Y(CAGR)

FAAR

+4.91%

CANC

N/A

Max(CAGR)

Winner

FAAR

+4.88%

CANC

-9.38%

FAAR vs CANC - Annual Returns (2016 - 2026)

Returns include dividend reinvestment.

Year	FAAR	CANC
2026	+22.25%	+8.37%
2025	+6.84%	+42.13%
2024	+5.74%	-6.11%
2023	-4.73%	+515.06%
2022	+10.10%	-85.58%
2021	+12.29%	-51.82%
2020	+11.07%	N/A
2019	-1.61%	N/A
2018	-8.92%	N/A
2017	+5.00%	N/A
2016	-3.78%	N/A

FAAR vs CANC Drawdown Comparison

The maximum drawdown for FAAR was -18.06%, occurring on Apr 8, 2025. Recovery took 901 trading sessions.

The maximum drawdown for CANC was -97.53%, occurring on Apr 5, 2023. This drawdown has not yet recovered.

The current FAAR drawdown is -3.52%. The current CANC drawdown is -55.25%.

Rank	FAAR	CANC
#1	-18.06% Jun 9, 2022 - Jan 13, 2026	-97.53% Oct 20, 2021 - Apr 5, 2023
#2	-16.65% May 21, 2018 - Feb 22, 2021	-16.18% Oct 5, 2021 - Oct 20, 2021
#3	-12.20% Jul 13, 2021 - Feb 7, 2022	N/A
#4	-6.77% May 3, 2017 - Jan 11, 2018	N/A
#5	-6.33% Mar 8, 2022 - Jun 9, 2022	N/A
#6	-5.93% Jul 13, 2016 - May 3, 2017	N/A
#7	-5.87% Jun 8, 2021 - Jul 13, 2021	N/A
#8	-5.76% Jan 24, 2018 - May 21, 2018	N/A
#9	-3.63% Feb 24, 2021 - Apr 29, 2021	N/A
#10	-3.52% May 18, 2026 - Jun 9, 2026	N/A
#11	-2.88% Jan 29, 2026 - Feb 19, 2026	N/A
#12	-2.70% Mar 20, 2026 - Apr 2, 2026	N/A
#13	-2.24% Apr 30, 2026 - May 18, 2026	N/A
#14	-2.03% Feb 11, 2022 - Feb 22, 2022	N/A
#15	-1.98% Feb 23, 2022 - Mar 1, 2022	N/A